The angiotensin converting enzyme (ACE) inhibitors are widely used in the management of
essential hypertension, stable chronic heart failure, myocardial infarction (MI) and diabetic …

Angiotensin converting enzyme inhibitors are established treatment for hypertension and
heart failure. There are well documented differences between ACE inhibitors both in …

Arterial hypertension occurs frequently in patients with chronic renal failure.
Antihypertensive treatment of arterial hypertension with angiotensin converting enzyme …

The pharmacology of angiotensin-converting-enzyme (ACE) inhibitors and their role in the
renin-angiotensin system (RAS) are described, and pharmacokinetic properties and …

The angiotensin converting enzyme inhibitors are an important therapeutic advance in the
treatment of patients with hypertension and congestive heart failure. In addition, they are …

The orally active angiotensin-converting inhibitors (ACE inhibitors) such as captopril and
enalapril represent a significant therapeutic advance in the treatment of hypertension and …

Although there is impressive documentation linking severe hypertension to renal
insufficiency, corresponding data for mild-to-moderate hypertension are only now starting to …

This review will discuss the safety profiles of the angiotensin-converting enzyme (ACE)
inhibitors captopril, enalapril and lisinopril in patients with hypertension. In general, the …

The expanding clinical indications for the use of angiotensin-converting enzyme (ACE)
inhibitors during the past three decades to reduce cardiovascular morbidity and mortality …

The inter-relationship between the pharmacokinetic and pharmacodynamic behaviour of
ACE inhibitors is reviewed. First, some of the methods which have been used to assess the …